← Back to Clinical Trials
Recruiting NCT06603584

NCT06603584 Phenotypes of Preschool Wheezing Among Children Attending Sohag University Hospital

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06603584
Status Recruiting
Phase
Sponsor Sohag University
Condition Wheezing
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2024-06-04
Primary Completion 2025-04-04

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 6 Years
Study Type OBSERVATIONAL
Interventions
Chest x- Rays

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2024-06-04 with a primary completion date of 2025-04-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Wheezing in preschool children is very common, with a wide differential diagnosis. It is essential to be sure of the exact sound that parents are describing; the term 'wheeze' is often applied to non-specific sound.Approximately one-third of children are diagnosed with wheeze in the first 3 years of life, making wheeze one of the commonest respiratory symptoms.The differential diagnosis of wheeze is wide, and different management strategies are needed depending on the underlying phenotype. The word 'wheeze' is used to describe many different sounds. That can be heard by both clincians and parent. Even if true wheeze is heard, this should not be automatically assumed to be due to bronchospasm. Airway narrowing by mucus will produce true wheeze but does not respond to bronchodilators. Similarly, airway malacia, either related to intrinsic airway wall defects or loss of alveolar tethering points, are also causes of bronchodilatorunresponsive wheeze; indeed, bronchodilators, by reducing airway smooth muscle tone, may actually worsen airway narrowing.

Eligibility Criteria

Inclusion Criteria: * patients from the age of one to five years with recurrent wheezing Exclusion Criteria: * Children above 5 years and below one year old. * Failure to obtain informed consent. * Children below 6 years with chest diseases other than wheezing

Contact & Investigator

Central Contact

Amr A Farghal, resident

✉ amrahmed@med.sohag.edu.eg

📞 01020479524

Frequently Asked Questions

Who can join the NCT06603584 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 6 Years, studying Wheezing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06603584 currently recruiting?

Yes, NCT06603584 is actively recruiting participants. Contact the research team at amrahmed@med.sohag.edu.eg for enrollment information.

Where is the NCT06603584 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT06603584 clinical trial?

NCT06603584 is sponsored by Sohag University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology